Cause of chemoresistance in small cell lung cancer discovered

July 18, 2017
Cause of chemoresistance in small cell lung cancer discovered. Credit: Medical University of Vienna

Approximately one year after successful treatment with cytotoxic chemotherapy and radiotherapy, patients with advanced Small Cell Lung Cancer (SCLC), which primarily affects heavy smokers, generally relapse with recurrence of tumours that are resistant to further chemotherapy. At this point, the affected patients usually only have a few months to live. The reason for this was hitherto unknown. Researchers at MedUni Vienna, led by Gerhard Hamilton (Department of Surgery), have now discovered that circulating tumour cells combine, making previously chemo-sensitive cells into chemo-resistant cell complexes.

"The circulating aggregate to protect themselves from chemotherapy – like a circle of covered wagons – thereby preventing any active agents from entering," says Hamilton, describing the process. These "aggregates" can comprise hundreds of thousands of cells, be up to 2 mm in diameter and be eight times more resistant to chemotherapy drugs – firstly because hypoxic conditions are created inside the aggregates and secondly because these tumour cells reduce growth and are therefore less sensitive. The results were recently published in the prestigious journal Scientific Reports from Nature Publishing Group.

These results were facilitated by the permanent cultivation of circulating tumour of patients with advanced SCLC in Vienna. This was the first time in the world that this had been done. The research group headed up by Hamilton and Robert Zeillinger (Molecular Oncology Group, Department of Obstetrics and Gynecology, MedUni Vienna) and Maximilian Hochmair (Otto-Wagner Hospital) successfully developed seven cell lines from blood samples and then analysed these in the laboratory.

"And so, after 30 years of uncertainty, we managed for the first time to identify the causes of chemo-resistance," explains Hamilton. The scientists now intend to conduct further studies to find out how to either prevent or destroy these cell aggregates. According to the MedUni Vienna expert, a highly promising approach is to break up the cell complexes using enzymes or inhibitors.

Lung cancer now leads the field when it comes to cancer-related mortality in women

Fifteen percent of people with have Small Cell Lung Cancer. By the time of diagnosis, SCLC has usually already formed metastases and surgery is no longer an option – the prognosis for those patients is therefore poor. Their prospects are even worse, if they have developed resistance to chemotherapy. "In such cases, patients usually only survive a few months," says Hamilton. "In view of the fact that cancer has now overtaken breast cancer as the commonest cause of death from cancer among women, that is alarming. Since 1972, the proportion of deaths among women due to lung has increased from 10 percent to 22 percent – a figure backed up by the latest results from Statistik Austria. Young people, in particular young women, who smoke should be aware of the high risk of developing SCLC, as well as other non-malignant diseases."

Explore further: Circulating small cell lung cancer cells successfully cultivated for the very first time

More information: Lukas Klameth et al. Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance, Scientific Reports (2017). DOI: 10.1038/s41598-017-05562-z

Related Stories

Circulating small cell lung cancer cells successfully cultivated for the very first time

November 19, 2015
Most cases of small cell lung cancer are only diagnosed after the tumour has already formed metastases. Until now it has not been possible to investigate the reasons for this rapid metastasis, because of a lack of sufficient ...

Newly discovered clues to the cause of chemoresistance in small cell lung cancer

April 4, 2016
Small cell lung cancer is not usually detected until it is at an advanced stage, when metastases have already formed. Chemotherapy is very effective initially but, within a year, cancer recurs and this time does not respond ...

Advanced radiotherapy improves lung cancer survival rates

July 4, 2017
A 10-year University of Manchester and Christie NHS Foundation Trust study which used advanced radiotherapy techniques in patients with limited-stage small cell lung cancer (SCLC) has achieved the best survival rates and ...

Blood test could predict best treatment for lung cancer

November 21, 2016
A blood test could predict how well small-cell lung cancer (SCLC) patients will respond to treatment, according to new research published in Nature Medicine today (Monday).

Protein biomarker as potential tool for predicting lung cancer survival

December 7, 2016
The biomarker PD-1, a protein, could potentially be used to predict survival or disease-free survival of lung cancer patients who have had the tumour surgically removed. This is substantiated by the results of a study conducted ...

Prognostic factor indicates risk of cancer recurrence following radical prostatectomy

June 27, 2016
Slightly more than 10% of all patients who undergo successful surgery for prostate cancer have an elevated risk of tumor recurrence afterwards – especially as metastases. Under the microscope, it is possible to identify ...

Recommended for you

Cancer vaccines need to target T cells that can persist in the long fight against cancer

September 25, 2017
Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer

September 25, 2017
A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing ...

Lung cancer treatment could be having negative health effect on hearts

September 25, 2017
Radiotherapy treatment for lung cancer could have a negative effect on the health of your heart new research has found.

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

'Labyrinth' chip could help monitor aggressive cancer stem cells

September 21, 2017
Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. ...

Whole food diet may help prevent colon cancer, other chronic conditions

September 21, 2017
A diet that includes plenty of colorful vegetables and fruits may contain compounds that can stop colon cancer and inflammatory bowel diseases in pigs, according to an international team of researchers. Understanding how ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.